Medical Licensing (MD/DO) · Independent exam preparation
ABPath Pediatric Pathology: Diagnostic Reasoning Guide Study Guide
Practise placental and neonatal diagnosis, pediatric tumor classification, biopsy adequacy, and ancillary-test interpretation for ABPath Pediatric Pathology certification.
By CertMedbry · Updated 16 October 2026
Learn to distinguish placental inflammatory responses, explain neonatal injury, assess biopsy adequacy, and integrate morphology with pediatric tumor genetics. This independent guide supports the American Board of Pathology Pediatric Pathology Subspecialty Certification Exam at fellow level, incorporating relevant core and advanced resident knowledge. Its 60 concepts are selective. Consult the official blueprint and final content specifications for the full preparation framework; ABPath also states that its specifications cannot list every topic needed for certification and practice.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification examination does this guide cover?
It covers the American Board of Pathology Pediatric Pathology Subspecialty Certification Exam. This is subspecialty board certification, not a general medical licensing examination. The specifications describe a fellow-level framework that incorporates applicable core and advanced resident knowledge.
Pediatric Pathology — ABPath · Pediatric Pathology Content Specifications
How many questions are administered, and which are scored?
ABPath lists 170 written/practical questions and 65 virtual microscopy questions, totalling 235 administered questions. The official descriptions cited here do not identify a scored versus pretest breakdown. These totals therefore do not establish scored-item counts.
Pediatric Pathology — ABPath · Pediatric Pathology Exam Blueprint — Updated for 2026
How long is the examination?
The examination takes place in one day. ABPath allocates 3 hours 8 minutes to written/practical sections and 3 hours 15 minutes to virtual microscopy. Those section times sum to 6 hours 23 minutes of testing. They do not establish the complete appointment length, including any breaks or administrative activities.
Pediatric Pathology — ABPath · Pediatric Pathology Exam Blueprint — Updated for 2026
How are questions delivered, and what item styles appear?
The examination is computer based, and all questions use a one-best-answer multiple-choice format. Practical material can include gross and microscopic images, cytogenetic preparations, graphs, charts, and special histochemical or molecular techniques. Microscopic material uses virtual microscopy; there are no glass slides. The cited description does not specify an adaptive algorithm or establish remote-proctoring arrangements.
Pediatric Pathology — ABPath · ABPath Virtual Microscopy Samples
Which blueprint and specifications apply to this guide?
This guide uses the official blueprint marked Updated for 2026 and the currently linked final content specifications dated October 13, 2025. Neither document states a separate day-level effective date, and the PDF upload directory is not an effective date. The current specifications index labels its link Final Version despite older generic draft wording elsewhere.
Pediatric Pathology Exam Blueprint — Updated for 2026 · Pediatric Pathology Content Specifications · Content Specifications for Examinations — ABPath · Subspecialty Exam Blueprints and Daily Schedules — ABPath
How should the two sets of domain percentages guide study?
Written/practical and virtual microscopy percentages are separate approximate distributions, each totalling 100%. For example, fetal/neonatal pathophysiology is 15% written/practical and 10% virtual microscopy; placental relationships are 7% and 10%; diagnostic/technical procedures are 7% and 2%. Laboratory management, forensic pathology, and general management each have written/practical weight but 0% virtual microscopy. Preserve both distributions when planning study rather than treating either as an overall examination percentage.
How should these questions and flashcards be used?
The 20 questions are independently authored four-option learning drills. They sample larger domains while maintaining organ-system breadth; a 20-item set cannot represent all 23 domains proportionally. Text vignettes do not reproduce the virtual microscopy interface, and results do not predict passing. Use the flashcards for active recall and the official virtual microscopy samples for interface familiarity.
Pediatric Pathology Exam Blueprint — Updated for 2026 · ABPath Virtual Microscopy Samples
Preparation centres on developmental context: the same finding can have different significance according to gestational age, childhood age, tissue compartment, and specimen handling. Diagnostic confidence requires connecting morphology with clinical timing, appropriate ancillary testing, and the limitations of each result.
Outline used: ABPath Pediatric Pathology Exam Blueprint, marked Updated for 2026, and currently linked final Pediatric Pathology Content Specifications dated 2025-10-13; verified on 2026-10-09. Neither document states a separate day-level effective date. The workbook label American Board of Pathology - Subspecialty in Pediatric Pathology maps to this examination; the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Perinatal Pathology: Placental-maternal-fetal relationships in pregnancyW/P=7%; VM=10%
1.Which placental compartments distinguish maternal from fetal acute inflammation?
Acute chorioamnionitis represents a maternal inflammatory response in the membranes or chorionic plate, whereas neutrophilic inflammation involving umbilical vessels or Wharton's jelly indicates a fetal inflammatory response. Funisitis therefore adds information about fetal participation rather than simply restating membrane inflammation. Identify the inflamed anatomical compartment before assigning significance. These lesions support an inflammatory process but do not independently identify its organism, establish neonatal bloodstream infection, or replace clinical assessment.
Apply it
A preterm placenta has neutrophils in the membranes and within an umbilical vein wall. Report maternal and fetal inflammatory components separately, explaining that the cord lesion demonstrates fetal participation without claiming culture-proven neonatal sepsis.
Common pitfall: Calling every neutrophilic placental lesion maternal chorioamnionitis loses compartment-specific information. Conversely, funisitis alone does not establish a particular pathogen or prove neonatal sepsis.
Placental acute inflammation infiltrates and pregnancy outcomes: a retrospective cohort study
2.How do p57 staining and genotyping distinguish hydatidiform moles?
The p57 protein is encoded by a maternally expressed, paternally imprinted gene. Typical androgenetic complete moles lack nuclear p57 in villous cytotrophoblast and stromal cells, while maternal decidua provides an internal positive control. Partial moles and nonmolar gestations generally retain staining, so retained p57 cannot separate them. Molecular genotyping resolves parental contribution, distinguishing androgenetic conception from diandric triploidy or a nonmolar genotype when morphology and immunostaining are insufficient.
Apply it
Hydropic villi show irregular contours and retained p57, but morphology cannot distinguish partial mole from nonmolar triploidy. Request parental-origin genotyping rather than treating a positive stain or triploid DNA content as a definitive molar classification.
Common pitfall: Retained p57 does not diagnose partial mole. Ploidy alone also misses the distinction between diandric and digynic triploidy because both contain three chromosome sets.
Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping
3.How do maternal and fetal vascular malperfusion differ?
Maternal vascular malperfusion concerns impaired delivery of maternal blood to the intervillous space; infarction and abnormal villous maturation can support that pattern. Fetal vascular malperfusion concerns obstruction or impaired flow within the fetal placental circulation; thrombi and downstream avascular villi are important clues. Interpret findings using distribution, gestational age, and clinical context. Distinguishing the two circulations is more informative than grouping every ischemic-looking lesion under an undifferentiated placental insufficiency label. Clinical definitions are detailed in the [Amsterdam Placental Workshop Group consensus statement](https://meridian.allenpress.com/aplm/article/140/7/698/65370/Sampling-and-Definitions-of-Placental-Lesions).
Apply it
A growth-restricted fetus has a placenta containing thrombi in large fetal vessels and clusters of avascular villi. Classify the dominant pattern as fetal vascular malperfusion and assess the cord and fetal vascular tree for associated abnormalities.
Common pitfall: Avascular villi should not automatically be attributed to maternal hypertension. A placental vascular pattern also does not independently establish an inherited thrombophilia in either patient.
4.Why does chorionicity matter in twin transfusion disorders?
Monochorionic twins share a placental circulation containing vascular connections, creating the anatomical basis for intertwin transfusion. Sustained net imbalance can produce a relatively hypovolemic donor and hypervolemic recipient, often accompanied by discordant amniotic fluid volumes in diamniotic pregnancies. Placental assessment therefore begins with chorionicity and membrane anatomy, followed by evaluation of the vascular territories and connections. Zygosity alone does not describe the shared circulation that makes this mechanism possible. See the [ISUOG twin-pregnancy guideline](https://obgyn.onlinelibrary.wiley.com/doi/10.1002/uog.29166).
Apply it
One twin has oligohydramnios and the other polyhydramnios. Examine the dividing membrane and placental vascular arrangement to establish chorionicity, then correlate the findings with donor-recipient physiology rather than relying only on the twins' similar appearance.
Common pitfall: Identical appearance does not establish monochorionic placentation. Discordant fetal size alone also does not prove twin-to-twin transfusion, because unequal placental sharing has other effects.
5.How does placenta accreta spectrum differ from placenta previa?
Placenta previa means placental tissue covers the internal cervical os. A low-lying placenta approaches but does not cover the os; after 16 weeks, RCOG uses a placental edge-to-os distance below 20 mm. These are location diagnoses. Placenta accreta spectrum instead describes abnormal uteroplacental attachment or invasion: villi abut myometrium without intervening decidua, invade myometrium, or extend through the uterine wall. Previa and accreta spectrum can coexist. Histological assessment of attachment requires an adequately represented, oriented uteroplacental interface and correlation with operative findings.
Apply it
At 24 weeks, ultrasound places the placental edge 12 mm from the internal os without coverage: this is low-lying placenta. Separately, villi directly adjoining myometrial fibres at a scarred hysterectomy interface support accreta spectrum. Assess location and attachment independently.
Common pitfall: Proximity to the os alone is not placenta previa, and low implantation does not itself establish accreta spectrum. A delivered placenta without uterine interface cannot establish maximum invasion depth.
Pediatric Pathology Content Specifications · bjog-2018-jauniaux-placenta-praevia-and-placenta-accreta-diagnos.pdf
Perinatal Pathology: Fetal/Neonatal pathophysiologyW/P=15%; VM=10%
6.Why can bilateral renal agenesis cause pulmonary hypoplasia?
Fetal urine becomes a major contributor to amniotic fluid during gestation. Bilateral renal agenesis can therefore produce early, severe anhydramnios, restricting the fluid environment and mechanical conditions needed for lung growth. Pulmonary hypoplasia is a downstream component of the renal anhydramnios sequence rather than necessarily a separate primary lung malformation. The RAFT trial supports the importance of that pathway, but survival after prenatal fluid intervention does not mean renal function has been restored.
Apply it
At fetal examination, both kidneys are absent, the pregnancy had longstanding anhydramnios, and the lungs are markedly small. Explain pulmonary underdevelopment through the renal-fluid sequence while documenting other abnormalities that might suggest an additional developmental disorder.
Common pitfall: Do not equate improved lung development after amnioinfusion with correction of renal agenesis. Respiratory survival and the burdens of absent kidney function remain separate clinical questions.
Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The RAFT Trial
7.When does CMV testing establish congenital infection?
Congenital CMV is established by detecting the virus in an appropriate infant specimen within the first three weeks after birth. Saliva PCR is useful, but a positive saliva result should be confirmed with urine because breast milk can contaminate oral samples. Testing performed later may not distinguish congenital from postnatally acquired infection. Sensorineural hearing loss can occur even when other neonatal findings are absent, making timing and specimen choice central to interpretation.
Apply it
A twelve-day-old infant has a positive saliva CMV PCR after feeding. Arrange urine confirmation within the congenital diagnostic window and preserve the timing in the interpretation, rather than treating the saliva result alone as definitive evidence.
Common pitfall: Maternal or infant CMV antibody results do not substitute for appropriately timed virologic testing. A first positive test months later cannot by itself establish congenital acquisition.
8.Which findings separate neonatal NEC from isolated intestinal perforation?
Necrotizing enterocolitis is an inflammatory and necrotizing intestinal disorder strongly associated with prematurity. Pneumatosis intestinalis, portal venous gas, and a broader pattern of bowel injury favour NEC. Isolated intestinal perforation more often presents as a focal perforation with relatively preserved surrounding bowel and without the characteristic extensive inflammatory-necrotic pattern. Clinical course, imaging, operative distribution, and histology must be integrated because free intraperitoneal air demonstrates perforation but does not identify its cause.
Apply it
An extremely preterm infant develops free abdominal air. Surgery finds a single small ileal defect with otherwise viable bowel, and imaging never showed pneumatosis. Integrate these findings as favouring isolated perforation while examining tissue for competing causes.
Common pitfall: Pneumoperitoneum is not synonymous with NEC. Conversely, absence of pneumatosis on one examination cannot exclude NEC when the clinical, operative, and histological pattern supports it.
Necrotizing Enterocolitis Surgery Trial Protocol · Necrotizing Enterocolitis — NICHD
9.How should immune and nonimmune fetal hydrops be distinguished?
Hydrops describes abnormal fluid accumulation in at least two fetal compartments, such as skin, pleural spaces, pericardium, or peritoneum. Immune hydrops results from maternal antibodies against fetal red-cell antigens, causing hemolytic anemia and secondary circulatory failure. Nonimmune hydrops encompasses other mechanisms, including cardiac dysfunction, nonimmune anemia, lymphatic abnormalities, infection, and metabolic disease. The anatomical finding establishes a physiological endpoint; maternal antibody studies and targeted examination determine the mechanism. See [SMFM Consult Series 75 on nonimmune hydrops](https://publications.smfm.org/publications/626-society-for-maternal-fetal-medicine-consult-series-75/).
Apply it
A hydropic fetus has ascites, pleural effusions, and severe anemia, but maternal red-cell antibody testing is negative. Investigate nonimmune causes of anemia and circulatory failure instead of assigning immune hydrops solely because anemia is present.
Common pitfall: Anemia does not make hydrops immune. Generalized postmortem swelling or a single isolated effusion also should not automatically be treated as documented multisystem fetal hydrops.
10.How do malformations, deformations, and disruptions differ?
A malformation arises from an intrinsic developmental error in an organ or structure. A deformation alters the shape or position of an initially normally formed structure through mechanical forces. A disruption destroys or interferes with previously normal developing tissue. These mechanisms guide interpretation of multiple anomalies: a sequence follows from one initiating event, whereas a syndrome reflects a recognizable shared cause. Describe the observed anatomy before selecting a mechanistic label or assuming a genetic explanation. These distinctions follow the [WHO/CDC birth-defects surveillance manual](https://archive.cdc.gov/www_cdc_gov/ncbddd/birthdefects/surveillancemanual/appendices/appendix-c.html).
Apply it
A fetus with prolonged oligohydramnios has positional foot abnormalities and facial compression. Explain these as deformations within a sequence, while separately assessing whether the renal abnormality that initiated fluid loss represents an intrinsic malformation.
Common pitfall: Several abnormalities do not automatically constitute a syndrome. Mechanical consequences of one primary lesion can create a sequence without requiring independent developmental errors in every affected structure.
11.Why is the premature germinal matrix vulnerable to hemorrhage?
The premature germinal matrix is a highly vascular, developmentally transient region with fragile vessels and vulnerability to fluctuations in cerebral blood flow. Hemorrhage commonly begins in the subependymal germinal matrix and may extend into the ventricular system. This mechanism differs from primary white-matter ischemic injury. Locate the initial lesion and its extensions rather than describing all premature brain injury as hypoxia, because hemorrhage, ventricular involvement, and white-matter injury represent distinct pathological observations. See the [AAP clinical report on neuroimaging of the preterm brain](https://publications.aap.org/pediatrics/article/146/5/e2020029082/75330/Routine-Neuroimaging-of-the-Preterm-Brain).
Apply it
A very preterm infant has blood centred beneath the ventricular lining with extension into the lateral ventricle. Identify germinal matrix hemorrhage with intraventricular extension, and examine adjacent white matter separately for additional ischemic or hemorrhagic injury.
Common pitfall: Intraventricular blood does not identify its source without anatomical assessment. Periventricular leukomalacia is a white-matter injury pattern and should not be used interchangeably with germinal matrix hemorrhage.
12.How should fetal growth restriction be interpreted at autopsy?
Fetal size must be interpreted against gestational age using reliable dating, body measurements, organ weights, and placental findings. Small size is an observation, whereas pathological growth restriction implies failure to reach growth potential. Placental malperfusion, infection, chromosomal disease, and other conditions can converge on that phenotype. Assess proportionality and associated abnormalities to direct investigation, but avoid assigning a cause from weight alone. Postmortem change and uncertain dating can further complicate developmental comparisons. The distinction between constitutional smallness and pathological restriction is emphasized in [ACOG guidance on fetal growth restriction](https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2021/02/fetal-growth-restriction).
Apply it
A fetus is small for the recorded gestation, but early ultrasound dating differs from the referral history. Reconcile dating first, then integrate measurements, placental lesions, and congenital abnormalities before deciding whether pathological growth restriction is established.
Common pitfall: Small for gestational age and growth restriction are not identical conclusions. A single low weight cannot establish placental causation or distinguish constitutional smallness from disease.
General Pathologic Principles and SyndromesW/P=5%; VM=5%
13.Why does the chromosome mechanism matter after a trisomy diagnosis?
A recognizable trisomy phenotype does not reveal whether the extra chromosomal material arose through nondisjunction, a structural rearrangement, or mosaicism. Chromosome analysis can distinguish these mechanisms and determine whether parental studies are relevant. A dosage-focused assay may identify extra material without fully characterizing its structural arrangement. The useful diagnostic question therefore extends beyond naming the syndrome to establishing the chromosomal mechanism, because that information changes interpretation of familial transmission and recurrence counselling. See the [AAP Down syndrome clinical report](https://publications.aap.org/pediatrics/article-pdf/149/5/e2022057010/1741492/peds_2022057010.pdf).
Apply it
An infant has features of trisomy 21 and a test demonstrating increased chromosome 21 dosage. Clarify whether the result characterizes chromosome structure; a translocation mechanism would make parental chromosome evaluation relevant to family counselling.
Common pitfall: Do not infer a sporadic nondisjunction mechanism from the phenotype or dosage result alone. Detection of extra material and characterization of its chromosomal arrangement answer different questions.
14.How does lysosomal glycogen accumulation produce Pompe disease?
Pompe disease results from deficiency of lysosomal acid alpha-glucosidase, impairing degradation of glycogen within lysosomes. Glycogen accumulation damages muscle, with severe infantile disease often involving both skeletal muscle and myocardium. This subcellular mechanism distinguishes Pompe disease from glycogen disorders centred on other metabolic steps. Vacuolated tissue can suggest the diagnosis, but enzyme testing and molecular confirmation establish the specific defect. Clinical severity depends on residual function and cannot be inferred from glycogen staining alone.
Apply it
An infant has hypotonia, feeding difficulty, cardiomegaly, and glycogen-containing muscle vacuoles. Prioritize acid alpha-glucosidase testing and confirmatory molecular assessment rather than diagnosing an unspecified glycogenosis from the biopsy appearance alone, despite the compelling clinical combination.
Common pitfall: PAS-positive material is not specific for Pompe disease. A lysosomal enzyme defect requires appropriate biochemical confirmation, and tissue appearance alone does not determine residual enzyme activity.
Pompe Disease: Diagnosis and Management — Canadian Expert Panel
15.Why must a suspected metabolic autopsy be planned before fixation?
Different investigations require separate preservation pathways. Promptly frozen liver or skeletal muscle can support selected enzyme, respiratory-chain, or other biochemical studies when collected according to the receiving laboratory's instructions. Unfixed skin placed in suitable sterile culture medium preserves the option of fibroblast culture; it must not be fixed or frozen if viable cells are required. Reserve a separate small tissue portion in the laboratory's recommended electron-microscopy fixative for ultrastructure, alongside routine formalin-fixed histology. Formalin can destroy enzyme activity and cell viability, while indiscriminate freezing destroys culture options and can damage ultrastructure. See [expert metabolic-autopsy specimen guidance](https://www.ncbi.nlm.nih.gov/books/NBK577012/table/ch9.t2/?report=objectonly).
Apply it
After an infant's unexplained metabolic decompensation and death, reserve rapidly frozen liver and muscle for selected biochemical assays, unfixed skin in culture medium for fibroblast studies, and separately fixed tissue for electron microscopy. Confirm assay-specific collection and transport requirements and document postmortem interval.
Common pitfall: One preservation method cannot serve every test. A normal routine section does not exclude metabolic disease, and fixed or frozen skin cannot subsequently provide the viable fibroblasts needed for culture.
Pediatric Pathology Content Specifications · Pompe Disease: Diagnosis and Management — Canadian Expert Panel
Cardiovascular SystemW/P=6%; VM=3%
16.Which anatomical findings define tetralogy of Fallot?
Tetralogy of Fallot comprises a ventricular septal defect, pulmonary outflow obstruction, an overriding aorta, and right ventricular hypertrophy. Outflow obstruction drives right ventricular pressure and promotes right-to-left flow across the septal defect, explaining cyanosis. The degree of obstruction therefore matters physiologically, rather than all four components contributing equally to immediate oxygenation. At examination, establish the relationships among ventricular septum, aortic root, and right ventricular outflow tract before interpreting secondary myocardial hypertrophy.
Apply it
A cyanotic infant's heart has a large ventricular septal defect and an aorta overriding the septum. Examine the right ventricular outflow tract for obstruction and assess right ventricular hypertrophy to complete the anatomical diagnosis.
Common pitfall: An overriding aorta and septal defect alone do not establish the complete tetrad. Right ventricular hypertrophy is a consequence of pressure loading, not the primary outflow obstruction.
17.Why can ductal closure unmask critical congenital heart disease?
The fetal ductus arteriosus connects pulmonary and systemic arterial circulations. Some severe congenital obstructions depend on that connection to maintain pulmonary or systemic blood flow after birth. As the ductus closes, an infant can deteriorate despite initially acceptable circulation. Determine which outflow pathway is obstructed and what circulation the ductus supplies. The same anatomical vessel can therefore support very different physiology depending on the underlying lesion and changing postnatal vascular resistances. The systemic-flow mechanism is illustrated in [CDC guidance on hypoplastic left heart syndrome](https://www.cdc.gov/heart-defects/about/hypoplastic-left-heart-syndrome.html).
Apply it
A newborn initially appears stable but develops shock as the ductus constricts. In assessing a markedly hypoplastic left-sided outflow tract, explain how ductal flow had supported systemic perfusion and why closure exposed the underlying obstruction.
Common pitfall: A patent ductus is not always the primary abnormality. In a duct-dependent lesion, treating its presence as an isolated excessive shunt misses its essential circulatory role.
18.Which cardiac tumor findings suggest a rhabdomyoma?
Cardiac rhabdomyomas are myocardial tumors that can be multiple and are associated with tuberous sclerosis complex. Their enlarged glycogen-rich cells can show cytoplasmic strands connecting the nucleus to the cell membrane, producing the classic spider-cell appearance. Interpret that morphology alongside anatomical location and multiplicity. A cardiac mass is not necessarily a sarcoma, and a benign histological diagnosis does not eliminate potential consequences from obstruction or interference with the cardiac conduction system. See the [International Tuberous Sclerosis Consensus Group cardiovascular guidance](https://pmc.ncbi.nlm.nih.gov/articles/PMC4338742/).
Apply it
Several ventricular myocardial nodules contain large vacuolated cells with radiating cytoplasmic strands. Diagnose a rhabdomyomatous lesion in context and communicate the association with tuberous sclerosis, while documenting any anatomical relationship to inflow, outflow, or conduction pathways.
Common pitfall: Skeletal-muscle terminology does not make rhabdomyoma malignant. Conversely, benign histology does not mean a cardiac mass is physiologically harmless when its location causes obstruction or arrhythmia.
Respiratory System and MediastinumW/P=6%; VM=6%
19.How does surfactant deficiency produce neonatal respiratory distress?
Surfactant lowers alveolar surface tension and helps keep distal airspaces open during expiration. In premature lungs, insufficient surfactant promotes collapse, reduced compliance, impaired gas exchange, and epithelial injury. Proteinaceous material and cellular debris can form hyaline membranes. Gestational age and onset shortly after birth support this mechanism, but respiratory distress is a clinical syndrome with other causes. Interpret hyaline membranes as an injury pattern within the developmental and clinical setting rather than an organism-specific finding.
Apply it
A very preterm neonate develops respiratory distress soon after delivery, and lung sections show collapsed airspaces with hyaline membranes. Explain the process through deficient surfactant and increased surface tension while considering any superimposed infection or treatment-related injury.
Common pitfall: Hyaline membranes are not proof of infection. Respiratory distress in a term infant also should not automatically be assigned the same prematurity-related mechanism without supporting evidence.
Newborn Breathing Conditions: Respiratory Distress Syndrome — NHLBI
20.How does bronchopulmonary dysplasia differ from initial surfactant deficiency?
Initial respiratory distress syndrome reflects surfactant deficiency and acute distal airspace instability. Bronchopulmonary dysplasia develops in the setting of prematurity and ongoing lung injury, with disturbed alveolar and pulmonary vascular development. Contemporary pathology often emphasizes simplified, enlarged airspaces and impaired septation rather than only dense scarring. Interpret the lungs using the infant's gestational age, postnatal age, respiratory course, and treatment exposure. Acute hyaline membrane disease and later chronic developmental injury can coexist but are not interchangeable diagnoses. Developmental abnormalities were demonstrated in the [primary morphometric study of BPD lungs](https://pubmed.ncbi.nlm.nih.gov/1990959/).
Apply it
A formerly extremely preterm infant dies after a prolonged respiratory course. Sections show simplified alveolar architecture with reduced septation. Interpret this as chronic disordered lung development in context rather than assuming persistent acute surfactant deficiency explains the entire course.
Common pitfall: Requiring marked fibrosis can miss the developmental pattern of contemporary bronchopulmonary dysplasia. Conversely, prematurity alone does not establish the diagnosis without the relevant respiratory course and findings.
Pediatric Pathology Content Specifications · Newborn Breathing Conditions: Respiratory Distress Syndrome — NHLBI
21.Which feature separates pulmonary sequestration from an airway malformation?
Pulmonary sequestration is characterized by abnormal lung tissue supplied by a systemic artery and lacking a normal connection to the tracheobronchial tree. Congenital pulmonary airway malformations are developmental abnormalities of airway architecture and can contain cystic spaces. Cyst appearance alone does not distinguish them, and hybrid lesions occur. Mapping the arterial supply and airway relationship is therefore central to classification, specimen dissection, and communication of the lesion's developmental anatomy. Hybrid anatomy is documented in a [primary series of cystic lung lesions with systemic arterial supply](https://pubmed.ncbi.nlm.nih.gov/9247218/).
Apply it
A resected lower-lobe lesion contains multiple cystic spaces, and imaging identifies an artery arising from the aorta. Preserve and document the feeding vessel, then assess airway anatomy before classifying the lesion or considering a hybrid developmental abnormality.
Common pitfall: Calling every congenital cystic lung lesion an airway malformation overlooks systemic arterial supply. Histological cyst size alone cannot replace imaging and gross assessment of vascular connections.
Central Nervous SystemW/P=5%; VM=6%
22.How is WNT-activated medulloblastoma established?
Medulloblastoma classification integrates embryonal tumor morphology with molecular grouping. WNT-pathway activation is associated with alterations such as CTNNB1 mutations and can be supported by nuclear beta-catenin staining, but subgroup assignment requires an appropriately validated integrated approach. Histological appearance or posterior fossa location alone does not establish WNT activation. Molecular classification matters because medulloblastomas with similar microscopic appearances can have different biological behaviour, clinical associations, and risk interpretations.
Apply it
A posterior fossa embryonal tumor has convincing medulloblastoma morphology and nuclear beta-catenin staining. Correlate the stain with validated molecular subgroup testing before issuing an integrated WNT-activated diagnosis or drawing conclusions about the individual child's prognosis.
Common pitfall: Do not equate every medulloblastoma with one biological risk group. A supportive immunostain should be interpreted within the laboratory's validated subgrouping strategy and complete diagnostic context.
Childhood Medulloblastoma and Other CNS Embryonal Tumors — NCI PDQ
23.Why does SHH-activated medulloblastoma require further stratification?
SHH-activated, TP53-altered medulloblastoma and SHH-activated, TP53-wild-type medulloblastoma are distinct integrated entities. Pathogenic TP53 alterations in childhood SHH disease, particularly beyond infancy, are associated with worse outcomes and greater treatment-failure risk. The altered entity also raises concern for a germline TP53 pathogenic variant and Li-Fraumeni syndrome; tumor testing does not establish germline status. Age, stage, histology, and other molecular features further refine risk. An unspecified TP53 variant or variant of uncertain significance must not automatically be treated as a pathogenic alteration.
Apply it
A nine-year-old's SHH-activated tumor contains a confirmed pathogenic TP53 alteration. Classify it as SHH-activated, TP53-altered medulloblastoma, recognize the adverse association in childhood disease, and recommend genetic counselling and germline assessment rather than equating its risk with TP53-wild-type SHH disease.
Common pitfall: SHH activation alone does not establish favorable risk. A TP53 variant of uncertain significance does not establish the altered entity, and a tumor pathogenic variant does not by itself prove Li-Fraumeni syndrome.
Childhood Medulloblastoma and Other CNS Embryonal Tumors — NCI PDQ
24.How can an atypical teratoid/rhabdoid tumor mimic medulloblastoma?
Atypical teratoid/rhabdoid tumor can contain primitive small cells and arise in locations that overlap other pediatric embryonal tumors. Rhabdoid morphology may be focal or inconspicuous, so its absence in a small sample does not exclude the diagnosis. Most tumors show loss of SMARCB1-related INI1 expression; a smaller subset involves SMARCA4-related BRG1 loss. Evaluate these proteins with intact internal controls and integrate the result with morphology and molecular findings rather than relying on patient age alone.
Apply it
An infant's posterior fossa tumor consists largely of primitive cells with only rare rhabdoid-appearing cells. Include INI1 and appropriate complementary evaluation in the workup rather than classifying the lesion as medulloblastoma solely from location and small-cell morphology.
Common pitfall: Rhabdoid appearance is neither required throughout the tumor nor specific by itself. Apparent protein loss is uninterpretable when nonneoplastic internal control cells also fail to stain.
Childhood Medulloblastoma and Other CNS Embryonal Tumors — NCI PDQ
SkinW/P=3%; VM=5%
25.How does endothelial GLUT1 support infantile hemangioma?
Infantile hemangioma is a vascular tumor with a characteristic proliferative and involutional course. Endothelial GLUT1 expression supports that diagnosis in the appropriate clinicopathological setting and helps distinguish it from many vascular malformations and other vascular lesions. The relevant staining is in lesional endothelium, not merely erythrocytes or unrelated positive structures. Interpret the marker with age at presentation, growth history, and architecture; positive staining does not by itself describe lesion extent or clinical consequences.
Apply it
A cutaneous vascular lesion appeared after birth, enlarged during infancy, and contains lobules of capillary-sized vessels. Endothelial GLUT1 positivity strengthens infantile hemangioma as the diagnosis when correlated with the history and overall tissue architecture.
Common pitfall: Erythrocytes can provide positive staining without proving lesional endothelial expression. A vascular lesion's presence in an infant alone does not distinguish a hemangioma from a malformation.
GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas
26.Which findings distinguish Langerhans cell histiocytosis from juvenile xanthogranuloma?
Langerhans cell histiocytosis typically contains lesional cells with grooved nuclei and expression of CD1a and langerin, often accompanied by eosinophils. Juvenile xanthogranuloma develops a different histiocytic pattern, sometimes with foamy cells and Touton giant cells, and lacks the characteristic Langerhans immunophenotype. Early lesions can be morphologically less distinctive, making a focused panel useful. Establish cell lineage from combined morphology and markers. See [pediatric LCH diagnostic guidance](https://pubmed.ncbi.nlm.nih.gov/29754886/) and a [primary report documenting the contrasting JXG phenotype](https://pubmed.ncbi.nlm.nih.gov/11488823/).
Apply it
A child's skin papule contains grooved histiocytes and numerous eosinophils, but no convincing Touton giant cells. Use CD1a and langerin to test a Langerhans lineage hypothesis rather than assigning juvenile xanthogranuloma solely from the patient's age.
Common pitfall: Eosinophils are supportive rather than specific. Absence of mature foamy cells or giant cells does not exclude an early juvenile xanthogranuloma, so morphology alone may be insufficient.
Special Senses-Eye and EarW/P=1%; VM=2%
27.Why does unilateral retinoblastoma still raise a germline question?
Retinoblastoma commonly involves inactivation of both functional copies of RB1 in a susceptible retinal cell. A constitutional first alteration creates a heritable predisposition, while additional somatic events lead to tumor formation. Bilateral or multifocal disease strongly suggests heritable disease, but unilateral disease does not exclude a germline alteration. Genetic assessment therefore cannot be replaced by laterality alone. The distinction matters for family evaluation and surveillance for additional tumors in an affected child.
Apply it
A child has a solitary unilateral retinoblastoma and no known family history. Explain that these features do not eliminate constitutional RB1 risk, and interpret genetic findings before classifying the tumor as definitively nonheritable for counselling purposes.
Common pitfall: Unilateral disease and a negative family history are not proof of purely somatic disease. A new germline alteration can occur without an affected parent or sibling.
Alimentary Tract-GIW/P=7%; VM=8%
28.What makes a rectal biopsy adequate for Hirschsprung assessment?
Hirschsprung assessment requires a correctly located biopsy with representative submucosa for evaluating ganglion cells and nerve structures. ERNICA recommends sampling the posterior or lateral rectal wall at least 2 cm proximal to the dentate line, or 3 cm from the anal orifice. Two or three suction biopsies are advisable to improve sampling. These are clinical recommendations, not ABPath examination rules. Sampling too distally risks the normally hypoganglionic zone; superficial mucosa cannot answer a submucosal innervation question. See the [updated ERNICA guideline](https://onlinelibrary.wiley.com/doi/10.1002/jpn3.70442).
Apply it
A neonate's suction biopsy contains mucosa and only a minute submucosal strip. Request adequately deep repeat sampling at the recommended rectal level, preferably obtaining two or three suction biopsies, rather than diagnosing aganglionosis from missing ganglion cells.
Common pitfall: Failure to identify ganglion cells in superficial or excessively distal tissue does not establish aganglionosis. Ancillary staining cannot reliably compensate for missing submucosa or an unsuitable sampling level.
Updated ERNICA guidelines for rectosigmoid Hirschsprung's disease 2025
29.How does calretinin assist the diagnosis of Hirschsprung disease?
Calretinin highlights ganglion cells and a characteristic network of mucosal nerve fibres in normally ganglionated bowel. Loss of that mucosal nerve-fibre pattern can support aganglionosis when the biopsy is correctly located and technically satisfactory. The stain supplements morphological examination and specimen adequacy assessment; it does not replace them. Interpret the relevant neural structures with appropriate controls, and recognize that individual positive nonneural cells do not establish normal enteric innervation in the sampled segment.
Apply it
An adequately located rectal biopsy has sufficient submucosa, no identified ganglion cells, and absent calretinin-positive mucosal nerve fibres with satisfactory controls. Integrate the concordant findings as supporting Hirschsprung disease rather than interpreting each observation in isolation.
Common pitfall: Scattered positive mast cells are not a normal mucosal neural network. Technical failure and unsuitable sampling must be excluded before treating absent calretinin staining as diagnostic.
Updated ERNICA guidelines for rectosigmoid Hirschsprung's disease 2025
30.How should a bowel resection for suspected NEC be sampled?
NEC can produce heterogeneous intestinal injury, ranging from mucosal damage to transmural necrosis and perforation. Sampling should document the distribution of injury, transitions to viable bowel, perforation sites, and represented margins rather than focusing only on the most dramatic defect. Histology is interpreted with imaging and operative findings because necrosis and perforation are not unique to NEC. The distinction from an isolated focal perforation depends partly on the condition of the surrounding intestine.
Apply it
A neonatal bowel resection contains one perforation and a separate dusky segment. Sample both lesions, intervening bowel, and margins, then compare the extent of inflammation and necrosis with operative observations before assigning the overall disease process.
Common pitfall: A block taken only from the perforation may obscure the distribution that distinguishes diffuse disease from a focal event. Necrosis alone does not establish a unique cause.
Necrotizing Enterocolitis Surgery Trial Protocol · Necrotizing Enterocolitis — NICHD
31.Why is villous atrophy insufficient by itself to diagnose celiac disease?
Celiac disease is an immune-mediated enteropathy in which villous shortening, crypt hyperplasia, and increased intraepithelial lymphocytes can support the diagnosis. These findings are not individually specific and must be interpreted with serology, dietary exposure, specimen orientation, and competing causes of mucosal injury. Poor orientation can simulate shortened villi, while treatment can alter both serological and histological findings. The diagnostic task is to integrate a characteristic pattern with an appropriate clinical and laboratory context. See the [ESPGHAN diagnostic guideline](https://onlinelibrary.wiley.com/doi/10.1097/MPG.0000000000002497).
Apply it
A child's poorly oriented duodenal fragments appear flattened, but serology and gluten exposure are undocumented. Request clinical correlation and evaluate better-oriented sections before calling celiac disease, while considering other causes of villous injury in the differential.
Common pitfall: Villous blunting is a pattern, not a disease-specific label. A gluten-restricted diet and poor orientation can complicate interpretation in different ways and should be recognized explicitly.
Hepatobiliary System and PancreasW/P=6%; VM=8%
32.When does persistent infant jaundice require evaluation for cholestasis?
Jaundice persisting beyond two weeks should prompt measurement of total and direct bilirubin to identify cholestasis. The joint society guideline identifies a direct bilirubin concentration above 1 mg/dL as abnormal and warranting timely evaluation. Conjugated hyperbilirubinemia is not explained by ordinary physiologic unconjugated jaundice. Stool colour, urine colour, growth, and examination help direct the workup, but reassuring appearance does not exclude a time-sensitive obstructive or metabolic disorder.
Apply it
A three-week-old infant remains jaundiced but feeds well. Total bilirubin is 7 mg/dL and direct bilirubin is 2 mg/dL. Recognize cholestasis and arrange timely etiologic evaluation instead of attributing the result to uncomplicated breast-milk jaundice.
Common pitfall: A direct bilirubin abnormality should not be dismissed because it forms a modest fraction of the total. Well appearance also does not exclude biliary atresia.
Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN
33.Which liver biopsy findings support biliary obstruction in an infant?
Portal expansion, ductular reaction, bile plugs, and portal fibrosis can support an obstructive pattern in an infant with cholestasis. These findings raise concern for biliary atresia but are not uniquely diagnostic, and early biopsies may be less characteristic. Histology must be integrated with the infant's age, stool history, imaging, and assessment of extrahepatic biliary patency. A pathology report should communicate both the pattern and its limitations without allowing equivocal morphology to falsely exclude obstruction.
Apply it
A jaundiced infant with pale stools has portal ductular proliferation and bile plugs on biopsy. Report a pattern supporting obstruction and correlate promptly with the biliary evaluation rather than diagnosing a specific extrahepatic anatomy from histology alone.
Common pitfall: An early nondiagnostic biopsy does not reliably exclude biliary atresia. Conversely, a ductular reaction is not specific enough to establish that diagnosis without the wider assessment.
Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN
34.How should bile duct paucity be assessed in an infant biopsy?
Use an explicitly stated counting convention. The comparative study by Zhou and colleagues defines paucity as an interlobular-bile-duct-to-portal-tract ratio at or below 0.5 in at least ten well-defined portal tracts. Count interlobular ducts rather than reactive ductules at the portal-parenchymal interface. Additional levels and CK7 staining can help identify ducts, but CK7 also highlights ductules, so anatomical identification remains essential. Interpret the result with gestational and postnatal age because developmental immaturity can complicate assessment. Early Alagille syndrome may lack established paucity; correlate with cardiac, skeletal, ocular, facial, and genetic findings.
Apply it
Four interlobular ducts across 12 well-defined portal tracts give a ratio of 4/12, approximately 0.33, meeting this operational definition after duct identification and developmental-age assessment. Six ducts across 12 tracts also meet the selected convention because its boundary includes 0.5. Three portal tracts do not meet its sampling requirement.
Common pitfall: Do not substitute reactive ductules for interlobular ducts or count repeated appearances of the same tract across serial levels as independent portal tracts. An inadequately sampled biopsy can misrepresent duct distribution, and absence of paucity on an early biopsy does not exclude Alagille syndrome. Paucity itself does not establish a single etiology.
Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN · Client Challenge
35.Why does parenteral nutrition not settle the cause of infant cholestasis?
Parenteral nutrition can contribute to infant cholestasis, particularly in medically complex premature infants, but exposure does not exclude a concurrent obstructive, infectious, genetic, or metabolic disorder. Histological features may overlap those of other cholestatic processes. Reconstruct the timing of bilirubin abnormalities relative to nutrition, illness, stool changes, and other exposures. The important decision is whether the proposed explanation accounts for the full course rather than merely being a plausible risk factor.
Apply it
A premature infant receiving parenteral nutrition develops pale stools and persistent direct hyperbilirubinemia. Review the entire timeline and pursue an appropriate biliary assessment instead of assuming the nutrition exposure accounts for every cholestatic finding in the case.
Common pitfall: A common exposure can anchor interpretation prematurely. Cholestasis predating parenteral nutrition or accompanied by obstructive clues requires consideration of another or an additional cause.
Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN
Kidney and Urinary SystemW/P=5%; VM=6%
36.How does triphasic differentiation support Wilms tumor?
Classic Wilms tumor can combine blastemal, epithelial, and stromal components, reflecting nephrogenic differentiation. Recognizing this combination supports the diagnosis, but not every tumor or biopsy contains all three elements. A predominantly blastemal sample requires a broader differential and appropriate ancillary evaluation. Histological assessment also includes features affecting classification and risk, so identifying a classic component is the beginning of interpretation rather than a substitute for representative sampling of the entire lesion.
Apply it
A child's renal mass contains primitive blue cells, small epithelial tubules, and spindle-cell stroma. Integrate these as nephroblastic differentiation, then sample heterogeneous areas and assess other relevant features rather than stopping after recognizing a triphasic pattern.
Common pitfall: Absence of all three components in a needle biopsy does not exclude Wilms tumor. Conversely, any childhood renal small-round-cell tumor should not automatically receive that diagnosis.
37.Why should nonneoplastic kidney be examined for nephrogenic rests, and how are hyperplastic perilobar rests distinguished from Wilms tumor?
Nephrogenic rests are persistent embryonal renal tissues associated with the developmental pathway to some Wilms tumors. Their distribution can inform assessment of predisposition and contralateral tumor risk. Sample suspicious background nodules together with their interface with native kidney. Hyperplastic perilobar rests and Wilms tumor may be cytologically identical; the useful architectural distinction is that perilobar rests generally lack the peritumoral fibrous capsule characteristic of Wilms tumor. A biopsy confined to the lesion's interior may therefore be insufficient to distinguish a hyperplastic rest from tumor.
Apply it
A nephrectomy contains a dominant Wilms tumor and smaller subcapsular nephroblastic nodules. Submit the smaller nodules separately, including adjacent kidney in the same blocks. Lack of a surrounding fibrous capsule supports a hyperplastic perilobar rest in the appropriate distribution. Document the rests and their type so their significance can be assessed alongside laterality, age, and genetic findings.
Common pitfall: Similar blastemal cytology does not make every background nodule another Wilms tumor. Conversely, failure to see a capsule in a core that lacks the lesion–kidney interface does not establish a rest. The capsule distinction is particularly useful for hyperplastic perilobar rests and should not be applied uncritically to every nephrogenic lesion.
Wilms Tumor and Other Childhood Kidney Tumors — NCI PDQ · Kidney.Wilms_4.4.1.0.REL_CAPCP.pdf
38.Which histological clues distinguish renal dysplasia from simple cystic dilation?
Renal dysplasia is disordered renal development, with abnormal tissue organization and structures such as primitive ducts surrounded by mesenchymal collars; cartilage may be present. Cysts alone do not establish dysplasia because several inherited and acquired processes produce cystic kidneys. Integrate gross distribution, collecting-system anatomy, obstruction, and associated malformations with histology. The discriminating question is whether renal development is fundamentally abnormal, rather than whether fluid-filled spaces are visible in the specimen. See the [ERKNet kidney-dysplasia consensus statement](https://academic.oup.com/ndt/article/37/12/2351/6623684).
Apply it
A cystic neonatal kidney contains primitive duct profiles with concentrically arranged mesenchyme and small cartilage islands. Diagnose a dysplastic developmental pattern and examine the urinary tract for associated abnormalities rather than labelling the specimen solely as polycystic kidney disease.
Common pitfall: Renal cysts are not specific for a hereditary polycystic disorder. Lack of cartilage does not exclude dysplasia when other convincing developmental abnormalities are present.
Endocrine System, excluding ovary and testisW/P=3%; VM=3%
39.How does 21-hydroxylase deficiency produce androgen excess and salt wasting?
Steroid 21-hydroxylase participates in cortisol and mineralocorticoid synthesis. Deficiency lowers cortisol production, increasing ACTH stimulation and adrenal precursor production, with diversion toward androgen synthesis. Severe deficiency also impairs aldosterone production, producing salt wasting, dehydration, and hyperkalemia. Elevated 17-hydroxyprogesterone supports the biochemical diagnosis, but neonatal screening results require appropriate interpretation and confirmation. The pathway explains why androgen excess and life-threatening mineralocorticoid deficiency can coexist in the same infant.
Apply it
A newborn has dehydration, hyponatremia, hyperkalemia, and markedly elevated 17-hydroxyprogesterone. Connect these findings to impaired cortisol and aldosterone synthesis with increased androgen production, and recognize the result as requiring urgent clinical correlation and confirmatory evaluation.
Common pitfall: Androgen excess does not imply adequate cortisol or aldosterone production. Prematurity and illness can complicate screening interpretation, so an isolated screening value is not the complete diagnosis.
40.Why is MYCN amplification interpreted within an integrated neuroblastoma risk assessment?
Neuroblastoma risk assessment integrates age, disease stage, histological features, and tumor biology. MYCN amplification is an important adverse biological feature, but no single result replaces the complete risk framework. Distinguish amplification from lesser copy-number gain and ensure the assay evaluates representative tumor. The diagnostic report should characterize the molecular finding accurately and avoid assigning an individualized prognosis solely from one marker without the clinical and pathological variables used by the relevant risk system.
Apply it
An adrenal neuroblastoma from a young child shows MYCN amplification. Communicate the adverse biological finding while integrating stage, age, and histology rather than assuming the child's young age makes the tumor uniformly favorable despite its molecular profile.
Common pitfall: MYCN copy-number gain and amplification are not interchangeable labels. A favorable age category cannot simply cancel adverse tumor biology without applying the complete risk framework.
Hematopoietic System, including bone marrow, lymph nodes, thymus, spleen and other lymphoid tissuesW/P=6%; VM=9%
41.How are blast lineages assigned using the WHO fifth-edition criteria for mixed-phenotype acute leukemia?
TdT indicates immaturity, not lineage. Under WHO fifth-edition criteria, strong CD19 means that expression in part of the leukemic population exceeds 50% of normal B-cell progenitor intensity; weak CD19 does not exceed that reference intensity. Strong CD19 requires at least one additional strongly expressed B marker among CD10, CD22, and CD79a; weak CD19 requires at least two. Do not use CD79a to establish B lineage when T lineage is under consideration. Cytoplasmic or surface CD3, assessed with an epsilon-chain antibody, establishes T lineage when intensity in part exceeds 50% of the mature T-cell level; immunocytochemical positivity with a non-zeta-chain reagent also qualifies. Myeloid assignment requires MPO intensity in part exceeding 50% of the mature neutrophil level, or monocytic differentiation demonstrated by at least two of nonspecific esterase, CD11c, CD14, CD64, and lysozyme.
Apply it
Blasts with strong CD19 and strong CD10 satisfy B-lineage criteria. If the same blasts also meet the MPO intensity criterion, assess B/myeloid mixed-phenotype acute leukemia. Integrate genetics: BCR::ABL1 and KMT2A rearrangements can define genetic MPAL categories, while AML-defining RUNX1::RUNX1T1, CBFB::MYH11, or PML::RARA abnormalities take precedence over aberrant lymphoid markers. BCR::ABL1 also requires exclusion of CML blast phase.
Common pitfall: The 50% benchmarks compare antigen intensity with reference cells; they do not require 50% of blasts to be positive. CD13 or CD33 alone does not establish myeloid lineage. Low-intensity MPO in otherwise typical B-ALL requires caution rather than automatic MPAL assignment. CD79a cannot supply the missing B-lineage evidence when T lineage is being evaluated.
Childhood Acute Myeloid Leukemia Treatment (PDQ®) - NCI · Childhood Acute Lymphoblastic Leukemia — NCI PDQ · Acute Myeloid Leukemia Treatment (PDQ®) - NCI
42.What does high hyperdiploidy mean in childhood B-ALL?
High hyperdiploidy in childhood B-ALL generally refers to a leukemic chromosome count in the 51–65 range and often carries favorable associations within contemporary treatment frameworks. Interpretation requires the actual chromosomal pattern rather than a generic statement that DNA content is increased. Other genetic lesions, patient features, and treatment response remain relevant. Before applying the favorable association, exclude a doubled hypodiploid clone, because a superficially high chromosome count can arise through a different biological pathway.
Apply it
A child's B-ALL has a chromosome count within the high-hyperdiploid range. Review the pattern of chromosome gains and supporting genomic data, then interpret the finding alongside other risk variables rather than assigning a prognosis from chromosome number alone.
Common pitfall: Increased DNA content is not automatically favorable hyperdiploid biology. The chromosome pattern and evidence of clonal doubling matter, and treatment response remains independently informative.
43.How can doubled hypodiploid B-ALL masquerade as hyperdiploidy?
A hypodiploid leukemic clone can undergo whole-genome doubling, producing a chromosome count that appears hyperdiploid or near triploid. This does not erase its hypodiploid origin or associated biological significance. The pattern may show paired chromosome losses, unusual tetrasomies, or extensive loss of heterozygosity, and a residual undoubled clone may be detectable. Integrating karyotype with allele-sensitive genomic analysis prevents a numerical chromosome count from being mistaken for a different leukemia subtype.
Apply it
An apparently hyperdiploid B-ALL has an unusual distribution of disomies and tetrasomies plus extensive loss of heterozygosity. Investigate a doubled hypodiploid origin before reporting favorable high hyperdiploidy or reassuring the treating team on that basis.
Common pitfall: Counting chromosomes without examining their allelic pattern can misclassify doubled clones. Failure to see an undoubled population does not exclude an underlying hypodiploid origin.
44.Why is hemophagocytosis insufficient to diagnose HLH?
HLH-2004 permits diagnosis through a compatible molecular diagnosis or five of eight criteria: fever; splenomegaly; cytopenias in at least two lineages—hemoglobin below 9 g/dL, or below 10 g/dL in infants younger than four weeks, platelets below 100 × 10^9/L, neutrophils below 1.0 × 10^9/L; fasting triglycerides at least 3.0 mmol/L (265 mg/dL) and/or fibrinogen at most 1.5 g/L; hemophagocytosis in marrow, spleen, or lymph nodes; low or absent NK-cell activity by local laboratory reference; ferritin at least 500 µg/L; and soluble CD25 at least 2,400 U/mL. Hemophagocytosis is neither sufficient nor invariably present, particularly early. Criteria can evolve, and ferritin elevation is nonspecific.
Apply it
A child has fever, splenomegaly, hemoglobin 8 g/dL with platelets 70 × 10^9/L, fasting triglycerides 320 mg/dL, and ferritin 2,000 µg/L. These satisfy five HLH-2004 criteria even without marrow hemophagocytosis. Assess the clinical syndrome and underlying genetic, infectious, malignant, or inflammatory cause promptly.
Common pitfall: Occasional hemophagocytes alone do not diagnose HLH, and a negative marrow does not exclude it. Two qualifying cytopenias constitute one criterion; triglyceride and fibrinogen abnormalities together also constitute only one criterion.
Pediatric Pathology Content Specifications · HLH-2004_ORIGINAL.pdf
BreastW/P=1%; VM=2%
45.How is a secretory breast carcinoma distinguished from a benign adolescent mass?
Age makes fibroadenoma a common consideration for an adolescent breast mass, but it does not establish benignity. Secretory carcinoma is an epithelial malignancy that can show intracellular and extracellular secretory material and is associated with ETV6::NTRK3. Fibroadenoma instead has a biphasic epithelial and stromal architecture. Assess architecture, cytology, and invasion before selecting ancillary tests. A fusion result requires anatomical context because it occurs in other tumor types. The breast association is demonstrated in the [primary ETV6::NTRK3 secretory-carcinoma study](https://pubmed.ncbi.nlm.nih.gov/12450792/).
Apply it
An adolescent breast lesion contains infiltrative epithelial tubules and abundant secretory material rather than a circumscribed biphasic proliferation. Investigate secretory carcinoma in context instead of allowing the patient's age to make fibroadenoma the automatic final diagnosis.
Common pitfall: Youth does not exclude breast carcinoma. ETV6::NTRK3 is also associated with tumors outside the breast, so its presence alone does not establish tissue lineage.
Pediatric Pathology Content Specifications · Childhood Soft Tissue Sarcoma — NCI PDQ
Female Reproductive SystemW/P=2%; VM=2%
46.Why does ovarian torsion cause hemorrhagic infarction?
Twisting of the ovarian vascular pedicle compromises venous and lymphatic drainage, producing congestion and edema; progressive vascular compromise can cause hemorrhagic infarction. A dark, hemorrhagic ovary does not establish a neoplasm or irreversible loss of viability. In a resected specimen, examine viable tissue and focal lesions for a contributing cyst or tumor. Extensive necrosis can limit classification. [ACOG guidance on adolescent adnexal torsion](https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/08/adnexal-torsion-in-adolescents) emphasizes ovarian preservation and cautions against inferring nonviability from gross colour alone.
Apply it
An adolescent's resected torsed ovary is enlarged and hemorrhagic, with a small residual viable peripheral nodule. Sample viable and lesional areas separately to document vascular injury and assess a possible underlying lesion rather than interpreting hemorrhage itself as tumor.
Common pitfall: Necrosis and hemorrhage can obscure an initiating lesion, but gross discoloration alone does not prove necrosis. A completely infarcted specimen may not support confident tumor classification.
Disorders of Sexual Development (Intersex disorders)W/P=1%; VM=2%
47.How does adrenal androgen excess differ from androgen insensitivity?
Steroid synthesis and tissue response are separate biological processes. In 21-hydroxylase deficiency, impaired adrenal cortisol synthesis increases ACTH-driven androgen production and can virilize a 46,XX fetus; severe forms also cause salt wasting. Androgen insensitivity instead concerns impaired androgen action in a person with testes and a 46,XY chromosome complement. Chromosomal findings, gonadal and internal anatomy, and steroid measurements must therefore be integrated rather than inferring mechanism from external appearance alone.
Apply it
A newborn with atypical external genital anatomy has a 46,XX result, a uterus, elevated 17-hydroxyprogesterone, and hyperkalemia. The combined findings support adrenal steroid synthesis failure with androgen excess rather than impaired androgen receptor response in a 46,XY individual.
Common pitfall: External anatomy does not establish chromosomes, gonadal tissue, or steroid pathway function. Adrenal androgen excess and androgen insensitivity should not be conflated because both affect sexual development.
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency — Endocrine Society Guideline · Pediatric Pathology Content Specifications
Male Reproductive SystemW/P=1%; VM=2%
48.Why can congenital adrenal hyperplasia produce testicular adrenal rest tumors?
Testicular adrenal rest tumors arise from adrenal-like tissue within the testis and can enlarge under chronic ACTH stimulation in congenital adrenal hyperplasia. They may be bilateral and can impair testicular function through their location and growth. Their endocrine context is central to interpretation because they can resemble other steroidogenic testicular lesions. Integrate CAH history, biochemical control, imaging distribution, and pathology before labelling a testicular mass as an unrelated primary neoplasm.
Apply it
An adolescent with longstanding classic CAH has bilateral testicular nodules near the mediastinal regions. Include adrenal rest tumors prominently in the assessment and correlate with endocrine history rather than assuming two independent primary testicular malignancies from imaging alone.
Common pitfall: Adrenal rest tumors are not testicular metastases from an adrenal cancer. Their resemblance to other steroidogenic cells makes clinical and anatomical context essential to classification.
Soft Tissue, Peripheral Nerve and MuscleW/P=4%; VM=6%
49.How does ETV6::NTRK3 support infantile fibrosarcoma?
Infantile fibrosarcoma is a spindle-cell sarcoma of early childhood, frequently associated with an ETV6::NTRK3 fusion. The fusion supports classification in an appropriate age, site, and morphological setting and can have therapeutic relevance. However, not every infantile spindle-cell tumor carries that exact fusion, and the alteration occurs in other tumor types. Interpret a targeted negative result according to assay coverage, and consider broader molecular evaluation when the morphology remains compelling.
Apply it
A young infant has a rapidly enlarging limb mass composed of densely cellular spindle cells. Integrate morphology with fusion testing; if a narrow ETV6::NTRK3 assay is negative, review its coverage before excluding the diagnostic category outright.
Common pitfall: A negative single-fusion assay does not exclude every relevant kinase fusion. A positive ETV6::NTRK3 result also requires anatomical context because it is not unique to infantile fibrosarcoma.
50.How should glycogen-filled muscle vacuoles be investigated?
Vacuolated muscle fibres containing glycogen suggest a metabolic myopathy, but the tissue compartment and biochemical defect must be established. In Pompe disease, lysosomal acid alpha-glucosidase deficiency produces lysosomal glycogen accumulation, often accompanied by autophagic disturbance. Morphology directs testing rather than uniquely identifying the disease. Correlate muscle findings with cardiac involvement, weakness pattern, enzyme assays, and molecular results, recognizing that fixation and processing influence what remains visible in a biopsy.
Apply it
A muscle biopsy from a hypotonic infant contains PAS-positive vacuoles, and echocardiography shows hypertrophic cardiomyopathy. Prioritize testing for a lysosomal glycogen disorder while retaining the broader metabolic differential until enzyme and genetic findings establish the specific cause.
Common pitfall: Vacuoles can contain different substances or reflect different mechanisms. PAS positivity and cardiomyopathy strengthen a hypothesis but do not replace a disease-specific biochemical diagnosis.
Pompe Disease: Diagnosis and Management — Canadian Expert Panel
51.Why does plexiform nerve growth require more than a benign-versus-malignant label?
A plexiform neurofibroma expands multiple nerve fascicles and has an important association with neurofibromatosis type 1. Recognizing the growth pattern provides syndromic information beyond a generic benign nerve-sheath diagnosis. Assessment of a changing lesion requires attention to focal architectural, cellular, and proliferative abnormalities because a heterogeneous mass may not be represented by one bland sample. Clinical change and representative sampling therefore matter alongside the baseline diagnosis. See the [ERN GENTURIS NF1 tumor-surveillance guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC9845795/).
Apply it
A child has a multinodular nerve-associated mass with a newly enlarging painful focus. Document the plexiform pattern and direct sampling to the changing region, rather than assuming a bland peripheral biopsy characterizes every part of the lesion.
Common pitfall: A benign background lesion does not establish that every new focus is equivalent. Conversely, increased size alone cannot establish malignant peripheral nerve sheath tumor without supporting assessment.
Pediatric Pathology Content Specifications · Childhood Soft Tissue Sarcoma — NCI PDQ
Skeletal SystemW/P=3%; VM=3%
52.Why are CD99 and EWSR1 rearrangement insufficient alone for Ewing sarcoma?
Ewing sarcoma typically combines compatible small-round-cell morphology with a defining fusion, most often EWSR1::FLI1. Strong membranous CD99 is useful but not specific, and EWSR1 rearrangements occur in several other neoplasms. An EWSR1 break-apart assay detects disruption of the locus without identifying its fusion partner. Integrated diagnosis therefore requires morphology, a relevant immunophenotypic differential, and sufficiently specific molecular characterization rather than treating either supportive result as a stand-alone disease label.
Apply it
An adolescent bone tumor is CD99 positive and EWSR1 break-apart positive, but morphology is atypical. Seek fusion-partner characterization and review competing entities before finalizing Ewing sarcoma, because both preliminary results have diagnostic boundaries that affect classification.
Common pitfall: EWSR1-rearranged is not synonymous with Ewing sarcoma. A negative break-apart result also requires consideration of assay limitations and the possibility of alternative relevant rearrangements.
53.Which finding establishes osteogenic differentiation in osteosarcoma?
Osteosarcoma is defined by malignant mesenchymal cells producing osteoid. The decisive feature is the relationship between atypical tumor cells and directly deposited osteoid, rather than the mere presence of bone in a specimen. Reactive bone, entrapped pre-existing trabeculae, and treatment-related changes can complicate interpretation. Integrate imaging, anatomic location, and representative histology, especially in small biopsies where a malignant lesion may be sampled without its diagnostic matrix-producing component.
Apply it
A teenager's destructive bone lesion contains pleomorphic cells directly depositing lace-like osteoid. Use that relationship to support osteosarcoma, while correlating with imaging to ensure the biopsy represents the lesion rather than adjacent reactive bone formation.
Common pitfall: Bone formation alone is not diagnostic of osteosarcoma. A small biopsy lacking osteoid may be unrepresentative, while reactive osteoblasts can appear active without representing malignant matrix production.
Pediatric Pathology Content Specifications · Osteosarcoma and UPS of Bone Treatment - NCI
Diagnostic/Technical ProceduresW/P=7%; VM=2%
54.What can a FISH probe establish about a genomic abnormality?
FISH uses fluorescent probes that bind specified nucleic-acid sequences, allowing their location, number, or arrangement to be assessed in cells. The probe design determines the question answered: a copy-number probe, break-apart probe, and partner-specific fusion probe provide different information. A normal result addresses only the targeted region within the assay's detection limits. Interpret signal patterns with cell selection, specimen quality, and controls rather than describing FISH as a comprehensive examination of the genome.
Apply it
A report states that an EWSR1 break-apart pattern is abnormal. Explain that this supports rearrangement of the targeted locus but does not name the partner; select a complementary assay if the diagnostic decision requires a specific fusion.
Common pitfall: A targeted normal FISH result does not exclude all genomic disease. A break-apart signal also does not identify every rearrangement partner or establish a unique tumor diagnosis.
Fluorescence In Situ Hybridization — NHGRI · Ewing Sarcoma — NCI PDQ
55.How should limited pediatric tumor tissue be triaged?
A small pediatric biopsy may need to support morphology, immunophenotyping, cytogenetics, and molecular analysis, but those methods do not all accept identically handled tissue. Triage begins with the clinical differential and communication before the entire sample is fixed or exhausted. Preserve representative morphology while reserving material for tests requiring viable cells or particular nucleic-acid quality. For suspected lymphoma, conventional flow cytometry needs suitable unfixed material. The handling principle is illustrated by the [CAP lymphoma protocol](https://documents.cap.org/protocols/nonhodgkinlymph-17protocol-3201.pdf); pediatric soft-tissue biopsy considerations are also detailed by NCI.
Apply it
A tiny core from a suspected hematolymphoid mass arrives fresh. Coordinate division for morphology and appropriate ancillary testing before placing all tissue in formalin, recording the limited amount and choosing a focused panel that addresses the main differential.
Common pitfall: More stains do not necessarily produce more diagnostic information. Exhausting the block on low-yield studies can prevent a decisive molecular or lineage test later in the workup.
Pediatric Pathology Content Specifications · Childhood Soft Tissue Sarcoma — NCI PDQ
56.Why is cell-free DNA screening not equivalent to fetal diagnosis?
Maternal plasma cell-free DNA screening estimates risk for targeted fetal chromosomal abnormalities using a signal largely derived from placental trophoblast. It is a screening test rather than a direct comprehensive fetal karyotype. Placental mosaicism and other biological factors can produce discordance. A positive result therefore raises a specific diagnostic question that may require chorionic villus sampling or amniocentesis, with specimen choice and interpretation accounting for whether placental or fetal material is being assessed. See [SMFM Consult Series 74 on cell-free DNA screening](https://publications.smfm.org/publications/620-society-for-maternal-fetal-medicine-consult-series-74cell/).
Apply it
A pregnancy has a positive cell-free DNA screen, but ultrasound is unremarkable. Explain that imaging does not convert the screen into a diagnosis and that confirmatory testing must address the targeted chromosomal question and possible placental-fetal discordance.
Common pitfall: A screening probability is not a fetal chromosome result. Chorionic villus sampling also examines placental tissue, so mosaic findings may require additional interpretation rather than automatic equivalence to fetal status.
Laboratory Management-Pediatric PathologyW/P=2%; VM=0%
57.Why must an immunostain be validated for an alternative fixative?
Fixation can alter antigen preservation, accessibility, and staining performance. An assay validated on routinely formalin-fixed tissue cannot automatically be assumed to perform equivalently on tissue exposed to another fixative or materially different processing. Validation must address the intended specimen conditions and diagnostic use, including appropriate positive and negative material. A technically attractive result is insufficient if sensitivity or specificity under the new conditions has not been established, especially when a negative stain drives exclusion of a disease.
Apply it
A pediatric biopsy arrives in an unfamiliar alternative fixative, and a decisive immunostain is negative. Check whether the assay is validated for that material and consider appropriate complementary testing before interpreting the result as true absence of the target.
Common pitfall: A successful stain on formalin-fixed control tissue does not prove equivalent performance in alternatively fixed patient tissue. Changing specimen conditions can create clinically important false-negative results.
Principles of Analytic Validation of Immunohistochemical Assays — CAP
58.Why do pediatric laboratory results require age-appropriate reference intervals?
Normal physiology changes rapidly during infancy and childhood, so a result outside an adult interval may be expected at a particular developmental stage. Reference intervals must also match relevant analytical conditions and population characteristics. Distinguish a reference interval from a clinical decision threshold: they answer different questions and are not always interchangeable. Verify age, units, method, and specimen context before interpreting an unexpected pediatric value. Age and analytical-platform effects are illustrated in the [CALIPER reference-interval initiative](https://pmc.ncbi.nlm.nih.gov/articles/PMC2605413/).
Apply it
An infant's laboratory result is flagged against an adult interval after a system update. Verify the age partition, units, and method-specific interval before escalating the finding, and correct the reporting configuration if the wrong comparator was applied.
Common pitfall: An adult interval should not be adopted merely because a pediatric value is unavailable. A reference interval also does not automatically define the threshold for diagnosis or treatment.
Forensic PathologyW/P=2%; VM=0%
59.How does SIDS differ from the broader category of SUID?
Sudden unexpected infant death describes an unexpected death in an infant younger than one year before its cause is determined. SIDS is a subset in which no cause is found after a thorough investigation, including autopsy, examination of the death scene, and review of clinical history. Other SUID deaths may be explained by accidental suffocation or another cause. Classification therefore depends on the complete investigation rather than an initially unexplained presentation or a nondiagnostic autopsy alone.
Apply it
An infant dies unexpectedly during sleep, and the autopsy reveals no anatomical cause. Keep the classification provisional until scene findings and history are integrated; absence of an autopsy diagnosis alone does not complete the investigation required for SIDS.
Common pitfall: SUID and SIDS are not interchangeable terms. A negative autopsy cannot substitute for scene investigation, and unsafe sleep circumstances require careful causal assessment rather than automatic classification.
Management & Informatics-GeneralW/P=2%; VM=0%
60.How do quality control and quality management address different failures?
Quality control monitors defined analytical processes, whereas quality management examines the broader pathway from specimen identification and handling through interpretation and communication. A valid analytical control cannot detect every wrong-patient or reporting error. Informatics safeguards therefore need to preserve identity, traceability, and appropriate result presentation across interfaces. When a discrepancy occurs, map where information or material changed, assess affected cases, and verify corrective action. These principles are addressed in the [WHO laboratory quality management handbook](https://www.who.int/publications-detail-redirect/9789241548274).
Apply it
All stain controls pass, but a report contains another patient's demographic details after an interface update. Investigate identification and data-transfer steps, assess other affected reports, and verify the correction rather than repeating the stain as the sole response.
Common pitfall: Passing controls support analytical performance, not the integrity of every preanalytical and postanalytical step. Correcting one report without addressing the underlying process leaves the same failure possible.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give substantial study time to fetal/neonatal pathophysiology: its written/practical weight is 15%, compared with 10% in virtual microscopy.
- Build compartment-based placental interpretation, separating maternal inflammation, fetal inflammation, maternal perfusion, and fetal vascular lesions.
- Practise virtual slide navigation and representative-field selection, especially for placental, hematopoietic, gastrointestinal, and hepatobiliary pathology.
- Integrate pediatric tumor morphology with lineage, fusion identity, copy-number patterns, and the limits of surrogate immunostains.
- Make specimen adequacy and handling explicit in rectal biopsy, liver biopsy, limited tumor sampling, and metabolic autopsy decisions.
- Study laboratory management, forensic pathology, and informatics directly; their 0% virtual microscopy weights do not remove them from written/practical scope.
A practical preparation plan
1. Map both official section blueprints
Create separate written/practical and virtual microscopy study columns. Place all 23 domains in each column with their official approximate weights, and use the final specifications to identify topics beyond this selective guide.
2. Learn mechanisms before isolated labels
For each entity, connect developmental timing, affected compartment, mechanism, and the finding that separates its closest mimic. Start with perinatal disease, then integrate organ-system pathology and pediatric neoplasia.
3. Practise slide interpretation as a sequence
Identify tissue and orientation, assess adequacy, survey architecture, select representative areas, and only then interpret cellular detail. State what the specimen demonstrates and which clinically important questions it cannot answer.
4. Build an ancillary-test decision table
For p57, calretinin, flow cytometry, FISH, fusion testing, and genomic arrays, record the biological target, required material, supportive result, limitations, and the complementary test needed when findings are discordant.
5. Use the drills to expose reasoning gaps
Answer the 20 questions without notes, then explain why each competing option fails. Revisit the relevant concept and use flashcards to recall mechanisms and boundaries rather than memorizing the option order.
6. Complete a scope and logistics check
Review lower-weight domains deliberately and consult the official outline for omitted topics. Confirm current scheduling instructions with ABPath and practise the virtual microscopy interface before undertaking timed mixed-domain review.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Pediatric Pathology — ABPath
- Pediatric Pathology Exam Blueprint — Updated for 2026
- Pediatric Pathology Content Specifications
- Content Specifications for Examinations — ABPath
- Subspecialty Exam Blueprints and Daily Schedules — ABPath
- ABPath Virtual Microscopy Samples
- Placental acute inflammation infiltrates and pregnancy outcomes: a retrospective cohort study
- Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping
- Neonatal Survival After Serial Amnioinfusions for Bilateral Renal Agenesis: The RAFT Trial
- Necrotizing Enterocolitis Surgery Trial Protocol
- Necrotizing Enterocolitis — NICHD
- Clinical Overview of CMV and Congenital CMV — CDC
- Tetralogy of Fallot — CDC
- Newborn Breathing Conditions: Respiratory Distress Syndrome — NHLBI
- Childhood Medulloblastoma and Other CNS Embryonal Tumors — NCI PDQ
- Updated ERNICA guidelines for rectosigmoid Hirschsprung's disease 2025
- Guideline for the Evaluation of Cholestatic Jaundice in Infants — NASPGHAN/ESPGHAN
- Wilms Tumor and Other Childhood Kidney Tumors — NCI PDQ
- Childhood Acute Lymphoblastic Leukemia — NCI PDQ
- Childhood Soft Tissue Sarcoma — NCI PDQ
- Ewing Sarcoma — NCI PDQ
- Fluorescence In Situ Hybridization — NHGRI
- Pompe Disease: Diagnosis and Management — Canadian Expert Panel
- Neuroblastoma — NCI PDQ
- GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency — Endocrine Society Guideline
- Principles of Analytic Validation of Immunohistochemical Assays — CAP
- Retinoblastoma — NCI PDQ
- About SUID and SIDS — CDC
- Client Challenge
- Acute Myeloid Leukemia Treatment (PDQ®) - NCI
- HLH-2004_ORIGINAL.pdf
- Osteosarcoma and UPS of Bone Treatment - NCI
- bjog-2018-jauniaux-placenta-praevia-and-placenta-accreta-diagnos.pdf
- Society for Maternal-Fetal Medicine Consult Series #75: Evaluation and management of non-immune hydrops fetalis - SMFM Publications and Clinical Guidelines
- Appendix C | Surveillance Manual | Birth Defects | NCBDDD | CDC
- Client Challenge
- Kidney.Wilms_4.4.1.0.REL_CAPCP.pdf
- Childhood Acute Myeloid Leukemia Treatment (PDQ®) - NCI
- Society for Maternal-Fetal Medicine Consult Series #74:Cell-free DNA screening for aneuploidies: Updated guidance - SMFM Publications and Clinical Guidelines
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.